Literature DB >> 36227899

Education and income-related inequalities in multimorbidity among older Brazilian adults.

Fabíola Bof de Andrade1, Elaine Thumé2, Luiz Augusto Facchini3, Juliana Lustosa Torres4, Bruno Pereira Nunes5.   

Abstract

OBJECTIVES: This study aimed to evaluate the existence of socioeconomic inequalities related to the prevalence of multimorbidity in the Brazilian population aged 60 and older.
METHODS: This was a cross-sectional study with data from the last Brazilian National Health Survey (PNS) collected in 2019. Multimorbidity was the dependent variable and was defined as the presence of two or more chronic diseases. All the diseases were assessed based on a self-reported previous medical diagnosis. Education and per capita family income were the measures of socioeconomic position. Socioeconomic inequalities related to multimorbidity were assessed using two complex measures of inequality; the Slope Index of Inequality (SII) and the Concentration Index (CI).
RESULTS: The prevalence of multimorbidity in Brazil was 56.5% 95% CI (55.4; 57.6) and varied from 46.9% (44.3; 49.6) in the North region to 59.3% (57.0; 61.5) in the South region. In general, individuals with higher socioeconomic positions had a lower prevalence of multimorbidity. Significant absolute and relative income inequalities were observed in the South region [SII -9.0; CI -0.054], Southeast [SII -9.8; CI -0.06], and Middle-east [SII -10.4; CI -0.063]. Absolute and relative education inequalities were significant for the country and two of its regions (Southeast [SII -12.7; CI -0.079] and South [SII -19.0; CI -0.109]).
CONCLUSIONS: The prevalence of multimorbidity is high in Brazil and all of its macro-regions. The significant findings concerning the inequalities suggest that the distribution of this condition is more concentrated among those with lower education and income.

Entities:  

Mesh:

Year:  2022        PMID: 36227899      PMCID: PMC9560520          DOI: 10.1371/journal.pone.0275985

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


Introduction

Chronic non-communicable diseases have been declared a global epidemic since 2011 [1]. It is estimated that more than 50% of the elderly population has two or more chronic diseases, a condition known as multimorbidity [2, 3]. In Brazil, approximately a quarter (24.2%) of the population aged 18 years and over has two or more chronic diseases [4] and for the population aged 60 years and over, the prevalence is 53.1% [5]. The accelerated population aging, especially in developing countries, makes multimorbidity one of the greatest challenges for health services, due to its association with functional decline [6, 7], use of health care services [8, 9] and mortality [10-12]. Among the different determinants of this condition, the impact of socioeconomic conditions has been increasingly studied with mixed results, depending on the measure of socioeconomic position and the country’s economic level [13-22]. A meta-analysis with 10 cross-sectional studies, representing 13 different populations, found that individuals with lower educational levels were 64% more likely to have multimorbidity than the ones with higher education. However, there was substantial heterogeneity between studies partly explained by the method of multimorbidity ascertainment. Moreover, different studies exploring measures of deprivation found a consistent positive association, while the evidence on income was mixed [13]. Studies addressing the socioeconomic inequalities related to multimorbidity in the elderly population are less common. In Brazil, among adults [4] and older adults [22, 23], they point to a negative association with schooling [4, 22, 23] and a positive association with the asset index [23]. In addition, few studies worldwide have evaluated these inequalities through complex measures, which are important to assess the effects of social policy [24]. The continuous evaluation of health inequalities is essential for reducing health disparities and its monitoring is an important target to achieve the United Nations Sustainable Development Goals [25]. Thus, this study aimed to evaluate the existence of socioeconomic inequalities related to the prevalence of multimorbidity in the Brazilian population aged 60 and older.

Methods

This was a cross-sectional study with data from the last Brazilian National Health Survey (PNS) collected in 2019. This is a household survey carried out by the Brazilian Institute of Geography and Statistics (Instituto Brasileiro de Geografia e Estatística–IBGE) in partnership with the Ministry of Health. The survey sample is representative of the Brazilian population residing in permanent private households, the five-country macro-regions, federation units, capitals, metropolitan areas and urban and rural regions. Sample selection was made by clusters into three stages. The primary sample unit was the census tracts or sets of tracts. In the second stage households from the National Register of Addresses for Statistical Purposes were selected. In the third stage, one resident aged 15 years old or over from each household was randomly selected. [26] Informed consent was obtained directly on the mobile data collection devices before the interview [26]. The survey data collections were approved by the National Commission for Ethics in Research/National Health Council, under protocol number 3,529,376. [26] The present study included participants aged 60 and older with complete information for the variables of interest including a sample of 22,728 individuals.

Dependent variable

Multimorbidity was defined as the presence of two or more chronic diseases, as proposed by the World Health Organization [27]. All the diseases were self-reported and included the following conditions: high blood pressure, diabetes, high cholesterol, heart disease, stroke, asthma, arthritis or rheumatism, chronic back problem, chronic obstructive pulmonary disease, work-related musculoskeletal disorder, cancer, chronic kidney failure, depression, other mental illness. Each of the diseases was evaluated through the following question, except for chronic back problem and other mental diseases: “Has a doctor ever diagnosed you with [name of disease]?”. chronic back problem, depression and other mental health diseases were evaluated by the questions, respectively: “Do you have any chronic back problems, such as chronic back or neck pain, low back pain, sciatica, spinal or disc problems?”; “Has a doctor or mental health professional (such as a psychiatrist or psychologist) ever given you a diagnosis of depression?” and “Has a doctor or healthcare professional (such as a psychiatrist or psychologist) ever given you the diagnosis of another mental illness, such as an anxiety disorder, from panic, schizophrenia, bipolar disorder, psychosis or OCD (Obsessive Compulsive Disorder) etc.?”

Independent variables

Measures of socioeconomic position (i.e., education and per capita family income) were the independent variables of interest. Education was categorized into six categories (no education, incomplete elementary school, complete elementary school, incomplete secondary, complete secondary, some college or more) and per capita family income into five categories (up to 1 minimum wage, >1–2 minimum wages, >2–3 minimum wages, >3–5 minimum wages, >5 minimum wages).

Data analyses

Data analyses included the description of the sample and the distribution of the multimorbidity according to the measures of socioeconomic position. Socioeconomic inequalities related to multimorbidity were assessed using two complex measures of inequality; the Slope Index of Inequality (SII) and the Concentration Index (CI). The SII is an absolute regression-based measure of inequality that takes the entire socioeconomic distribution into account, rather than just comparing the two most extreme groups [28]. To calculate the SII each category of the socioeconomic position measure (i.e. education, income) is assigned a relative position score based on the midpoint of the range of the cumulative distribution of the population of participants in each category. Individuals were cumulatively ranked from 0 to 1 according to socioeconomic position, in ascendent order, such that "0" represents the lowest level of socioeconomic position and "1" represents the highest level of socioeconomic position. The relative position variable will then be entered as an independent variable in the regression model. Because the outcome is binary, the SII was estimated with logistic regression to avoid predicting values in the regression model that were outside the interval between 0 and 1. [29] The SII is the difference in probability (absolute inequality) between those at the highest level of socioeconomic status and those at the lowest level. An SII value lower than zero indicated that the prevalence of multimorbidity is higher among populations in lower socioeconomic positions [24]. The CI proposed by Wagstaff was used in the study to analyze the relative inequalities [30]. This measure can be used to show how the health indicator is distributed across individuals that are ranked by a socioeconomic position measure. The concentration index is defined as twice the area between the concentration curve and the line of equality [24, 30]. CI varies between -1 and +1; when there is no socioeconomic-related inequality, CI is zero. A positive value indicates that the rich have a higher prevalence of multimorbidity than the poor (pro-rich inequality), and a negative value indicates a disproportionate concentration of multimorbidity among poor individuals (pro-poor). [24] The CI was estimated using the Stata command conindex. Details about its estimation have been reported previously [30]. All analyses were performed using the Stata 15.0 software and took into account the complexity of the survey sampling design.

Results

Table 1 shows the characteristic of the Brazilian older adults included in the study. Most of the participants were female and had 60–69 years old. Considering the socioeconomic position measures, a higher proportion of individuals had no education (16.8%) or incomplete elementary school (46.5%). About 41.7% reported receiving up to one minimum wage, whereas 7.4% reported 5 or more.
Table 1

Distribution of the population.

% (95% CI)
Age (years)
60–6956.3 (55.2–57.4)
70–7930.1 (29.2–31.1)
80+13.6 (12.8–14.3)
Sex
Male43.3 (42.2–44.4)
Female56.7 (55.6–57.8)
Income
Up to 1 minimum wage41.7 (40.6–42.9)
>1–2 minimum wages31.9 (30.8–32.9)
>2–3 minimum wages10.8 (10.1–11.5)
>3–5 minimum wages8.2 (7.6–8.9)
>5 minimum wages7.4 (6.7–8.1)
Education
No education16.8 (16.0–17.7)
Incomplete elementary school46.5 (45.3–47.6)
Complete elementary school6.8 (6.3–7.4)
Incomplete secondary2.7 (2.4–3.1)
Complete secondary14.5 (13.7–15.4)
Some college or more12.7 (11.9–13.6)
Country regions
North6.1 (5.8–6.4)
Northeast25.4 (24.5–26.2)
Southeast46.4 (45.3–47.6)
South15.7 (15.1–16.4)
Middle-east6.4 (6.0–6.8)
The prevalence of multimorbidity in Brazil was 56.5% 95% CI (55.4; 57.6) and varied from 46.9% (44.3; 49.6) in the North region to 59.3% (57.0; 61.5) in the South region. The prevalence in the Northeast, Middle-east and Southeast were, respectively, 53.1% (51.2; 55.0), 57.3% (54.6; 60.0) and 58.5% (56.6; 60.4). The distribution of multimorbidity by education and family income per capita is presented in Fig 1. In general, individuals with higher socioeconomic positions had a lower prevalence of multimorbidity, but different patterns were found and a linear pattern was only observed for the southeast region concerning income.
Fig 1

Prevalence of multimorbidity by income and education.

Significant absolute and relative income inequalities were observed in the South region [SII -9.0; CI -0.054], Southeast [SII -9.8; CI -0.06] and Middle-east [SII -10.4; CI -0.063], being the prevalence of multimorbidity more concentrated among individuals with lower socioeconomic positions. Education inequalities were in the same direction as income inequalities. Absolute and relative indexes were significant for the country and two of its regions (Southeast [SII -12.7; CI -0.079] and South [SII -19.0; CI -0.109]). In the country, the prevalence of multimorbidity was 5.1 percent points higher among individuals at the lower educational level than in those at the higher and the concentration index was -0.031 (Table 2).
Table 2

Slope index and concentration index of inequality by education and income.

 IncomeEducationIncomeEducation
 SII (95% CI)SII (95% CI)CIX (95% CI)CIX (95% CI)
Brazil -2.7-5.1-0.015-0.031
(-6.9; 1.5)(-8.9; -1.3)(-0.039; 0.010)(-0.054; -0.008)
North -5.3-6.0-0.025-0.036
(-15.6; 5.1)(-15.0; 3.0)(-0.074; 0.024)(-0.089; 0.018)
Northeast 6.24.50.0270.027
(-2.4; 14.7)(-1.9; 10.9)(-0.009; 0.064)(-0.012; 0.065)
Southeast -9.8-12.7-0.060-0.079
(-16.7; -2.8)(-19.2; -6.2)(-0.103; -0.017)(-0.120; -0.038)
South -9.0-19.0-0.054-0.109
(-17.7; -0.3)(-26.6; -11.3)(-0.107; -0.002)(-0.153; -0.065)
Middle-east -10.4-6.2-0.063-0.038
(-20.4; -0.4)(-16.7; 4.2)(-0.124; -0.002)(-0.102; 0.026)
The quadrant graph (Fig 2) was used to compare the CI and prevalence of multimorbidity for each region with the corresponding values of the country. Most of the regions (Middle-east, South and Southeast), for income inequalities, were concentrated in the bottom right quadrant, but the magnitude of the CI was similar among these regions.
Fig 2

Concentration index by the prevalence of multimorbidity.

Notes for Fig 2: Hollow markers are non-significant. Horizontal dashed line = education CI. Horizontal solid line = income CI.

Concentration index by the prevalence of multimorbidity.

Notes for Fig 2: Hollow markers are non-significant. Horizontal dashed line = education CI. Horizontal solid line = income CI.

Discussion

This study showed a high prevalence of multimorbidity in Brazil and all of its macro-regions. The findings suggest that older adults in lower socioeconomic positions have a higher prevalence of multimorbidity. An absolute and relative education inequality was observed within the country, whereas significant inequalities for both education and income were observed within the Southeast and South regions. Within the Middle-east region, only income-related inequalities were observed. Previous studies using either the SII or CI to evaluate inequalities in multimorbidity used a different combination of diseases and a variety of socioeconomic position measures [i.e. asset index [21, 31], income [32], purchasing power [33] and schooling [33, 34]] making it difficult a direct comparison between the results. In most of the countries evaluated in these studies [21, 31, 32, 34], the concentration index was negative as in the present study, thereby demonstrating a pro-poor inequality, where the prevalence of multimorbidity is highly concentrated among the poor. None of the studies exclusively investigated older adults. The study by Kunna et al. evaluated a sample of individuals 50 and older from China and Ghana. Within the latter country, the CI for household assed-inequalities was pro-poor CI -0.0801 (95% CI -0.1233; -0.0368), but in the former country it was found to be pro-rich [CI 0.1453 (95% CI 0.0794; 0.2083)], being the prevalence of multimorbidity more concentrated among the rich [21]. In Brazil, two previous studies used both of these measures of inequalities and found opposite results [33, 34]. Findings from a nationwide sample of Brazilian adults, aged 20 to 59 years [33] reported pro-rich absolute and relative inequality by purchasing power and education among adult men. On the other hand, inequalities were absent among women. Unlike the latter study and corroborating the present findings, Delpino et al. [34] found that, for both absolute and relative inequalities, multimorbidity was more concentrated among Brazilian adults with lower educational level in 2013 SII -11.2 (IC95% -13.6; -8.7); CI -0.07 (95% CI -0.09; -0.05) and in 2019 [SII -10.1 (IC95% -12.2; -7.9)].; CI -0.05 (95% CI -0.07; -0.04). The magnitude of absolute inequalities was higher than the relative ones and the findings also suggest that they are smaller than the ones observed among Brazilian adults in the same year [34]. These differences may rely on the fact that the prevalence of multimorbidity is higher among older adults which has a direct impact on the estimated indexes. In contexts where the prevalence is high, it is expected a smaller relative inequality in comparison to absolute. The concentration index tends to be lower at larger overall levels of the outcome [35] and absolute measures are expected to be low at both very low and very high overall levels of the outcome [36]. Moreover, these measures might give different answers to the existence of inequalities, although in the present study similar findings were confirmed by both. Thus, besides reporting both measures of absolute and relative inequalities, the prevalence of the outcome should be presented alongside inequality data to give a better understanding of the scenario [24]. As observed in the country, the prevalence of multimorbidity was high in its regions, which showed similar patterns for income and education inequalities. Considering the magnitude of the indexes for the country and its regions, on the contrary of what was observed for absolute inequalities, relative indexes might be considered reasonably small, although there is no consensus on a specific cutoff point. Accordingly, it has been reported [24] that absolute values for the concentration index rarely exceed 0.5, then values of 0.2 to 0.3 are considered to represent a reasonably high level of relative inequality. This study built on the existing literature by estimating for the first time the magnitude of relative and absolute inequalities, among older adults, using complex measures and two socioeconomic position stratifiers (i.e., schooling and household per capita income). The findings show that the direction of the inequalities was the same for both income and education, but a different pattern of significance was found. As for the relative and absolute indexes, different socioeconomic position measures might give different results as the mechanisms by which they impact health throughout life are distinct, although they may overlap [37, 38]. Income directly accesses actual material resources and might represent health-relevant disposable income for the individuals [37] (e.g., access to medical diagnosis). Moreover, at retirement ages income are more stable among individuals [39]. Education, on the other hand, captures the long-term influences of early life circumstances on adult health and the influence of adult resources on health as it is also related to income and wealth in the life course [40]. Another strength of this measure is its relation to health literacy, thereby influencing the individual’s ability to understand, report and engage with health information and services [40, 41] and to adopt healthier behavior. The major strength of this study is the use of a national sample of older adults and the possibility to evaluate the existence of inequalities in Brazil and its macro-regions, which are historically different. The Brazilian National Health Survey, carried out in 2019, is the most recent household health survey in the country, due to its systematic methodology and periodicity, is appropriate for this analysis and makes it possible the comparison of its findings throughout the time. The use of complex measures of inequalities is also worth noting. Among the limitations, the restricted number of diseases and as well as the use of self-reported diseases might have impacted the prevalence of multimorbidity towards a lower estimate. However, the use of a question addressing a physician diagnosis might improve the report [42, 43], albeit a small effect is expected among individuals in the lower socioeconomic position for which the access to medical diagnosis is least frequent. Based on the findings of this study, it is possible to conclude that multimorbidity affects a significant proportion of the older Brazilian population and its prevalence is high in all of the country’s macro-regions. The higher prevalence of this condition is more concentrated among the ones with lower education and income in the country. There are differences in the distribution of relative and absolute inequalities among the country regions. These findings highlight the importance of continually evaluating within regions’ differences as the country’s mean values of inequalities hide the specificities of each of them. 4 Aug 2022
PONE-D-22-16455
Education and income-related inequalities in multimorbidity among older Brazilian adults
PLOS ONE Dear Dr. Bof de Andrade, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ACADEMIC EDITOR:
============================== Please consider all suggestions made by reviewers. Please submit your revised manuscript by Sep 18 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Marcus Tolentino Silva Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf. 2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. 3. Thank you for stating the following financial disclosure: FBA - This work was supported by Foundation for Research Support from Minas Gerais State (FAPEMIG), Brazil [grant APQ-00573-21]. http://www.fapemig.br/pt/ Funder role: none. Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Bof de Andrade and colleagues conducted a cross-sectional analysis to explore the association between socioeconomic inequalities and the prevalence of multimorbidity in the general population aged 60 years or older, using nationally-representative data retrieved from the most recent Brazilian National Health Survey. The study findings suggest that individuals with higher socioeconomic status tend to have a lower prevalence of multimorbidity in Brazil. The study carries important implications for health equity across different regions, despite room for improvement through a minor revision. The estimation of the slope index of inequality (SII) and the concentration index (CI), which were adopted as measures of inequality in the study, were not explicitly explained. For example, it remains to be elucidated as to how the regression models were constructed to yield the inequality coefficient. Besides, the authors may wish to add a bit more elaboration on how the confounding factors were accounted for in the study. Reviewer #2: The lines in the article are not numbered. In the abstract the conclusion should provide more information on the distribution of multimorbidity in the country, as it is, the conclusion is to general and more detailed information on the most affected areas of the country could be helpful. In the first paragraph of the introduction reference 4 is in () and not in []. Methods: In the independent variables, the education variable is defined with six categories, but one category is missing in the parenthesis, but then it is mentioned in table 1. Add the category in the text “some college or more”. In the discussion, a closing paragraph should be included regarding the inequality differences found in the different regions of the country and its relationship with the high multimorbidity prevalence. This was not evident in the discussion. There is no conclusion in the manuscript, include it ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Harry H.X. Wang Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
11 Aug 2022 Reviewer #1: Bof de Andrade and colleagues conducted a cross-sectional analysis to explore the association between socioeconomic inequalities and the prevalence of multimorbidity in the general population aged 60 years or older, using nationally-representative data retrieved from the most recent Brazilian National Health Survey. The study findings suggest that individuals with higher socioeconomic status tend to have a lower prevalence of multimorbidity in Brazil. The study carries important implications for health equity across different regions, despite room for improvement through a minor revision. The estimation of the slope index of inequality (SII) and the concentration index (CI), which were adopted as measures of inequality in the study, were not explicitly explained. For example, it remains to be elucidated as to how the regression models were constructed to yield the inequality coefficient. Besides, the authors may wish to add a bit more elaboration on how the confounding factors were accounted for in the study. Response: Thanks for the careful review of our manuscript and for the suggestions. We have included more information on how to estimate the indexes and included references for the papers that detailed explained the methods. Regarding the confounders, they were not discussed because in these analyses only the outcome and the socioeconomic position measures are included. Reviewer #2: The lines in the article are not numbered. Response: Thanks for the careful review of our manuscript and for the suggestions. We have included the lines numbers in the paper. In the abstract the conclusion should provide more information on the distribution of multimorbidity in the country, as it is, the conclusion is to general and more detailed information on the most affected areas of the country could be helpful. Response: Thanks for the suggestion. We included this information in the abstract. In the first paragraph of the introduction reference 4 is in () and not in []. Response: We have made the change. Methods: In the independent variables, the education variable is defined with six categories, but one category is missing in the parenthesis, but then it is mentioned in table 1. Add the category in the text “some college or more”. Response: We have included the category. In the discussion, a closing paragraph should be included regarding the inequality differences found in the different regions of the country and its relationship with the high multimorbidity prevalence. This was not evident in the discussion. Response: We highlighted this information in the discussion section in the paragraph where the magnitude of the inequalities is discussed. There is no conclusion in the manuscript, include it Response: We have reviewed the discussion to better address the conclusions. Submitted filename: Response to Reviewers.doc Click here for additional data file. 26 Sep 2022 Education and income-related inequalities in multimorbidity among older Brazilian adults PONE-D-22-16455R1 Dear Dr. Bof de Andrade, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Marcus Tolentino Silva Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank the authors for addressing my previous comments. The paper can be considered for acceptance for publication. Reviewer #2: One last revision: in line 287, the redaction is confusing, change “these findings the importance of…” to “these findings highlight the importance of” ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Harry H.X. Wang Reviewer #2: No ********** 3 Oct 2022 PONE-D-22-16455R1 Education and income-related inequalities in multimorbidity among older Brazilian adults Dear Dr. Bof de Andrade: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Marcus Tolentino Silva Academic Editor PLOS ONE
  39 in total

1.  conindex: Estimation of concentration indices.

Authors:  Owen O'Donnell; Stephen O'Neill; Tom Van Ourti; Brendan Walsh
Journal:  Stata J       Date:  2016 1st Quarter       Impact factor: 2.637

2.  Effect of education and multimorbidity on mortality among older adults: findings from the health, well-being and ageing cohort study (SABE).

Authors:  G M Bernardes; H Saulo; J L F Santos; D S da Cruz Teixeira; Y A de Oliveira Duarte; F Bof de Andrade
Journal:  Public Health       Date:  2021-11-15       Impact factor: 2.427

3.  Education and occupational social class: which is the more important indicator of mortality risk?

Authors:  G Davey Smith; C Hart; D Hole; P MacKinnon; C Gillis; G Watt; D Blane; V Hawthorne
Journal:  J Epidemiol Community Health       Date:  1998-03       Impact factor: 3.710

4.  Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.

Authors:  Karen Barnett; Stewart W Mercer; Michael Norbury; Graham Watt; Sally Wyke; Bruce Guthrie
Journal:  Lancet       Date:  2012-05-10       Impact factor: 79.321

Review 5.  Measuring socioeconomic position in health research.

Authors:  Bruna Galobardes; John Lynch; George Davey Smith
Journal:  Br Med Bull       Date:  2007-02-06       Impact factor: 4.291

6.  Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort.

Authors:  Bhautesh Dinesh Jani; Peter Hanlon; Barbara I Nicholl; Ross McQueenie; Katie I Gallacher; Duncan Lee; Frances S Mair
Journal:  BMC Med       Date:  2019-04-10       Impact factor: 8.775

7.  Global Multimorbidity Patterns: A Cross-Sectional, Population-Based, Multi-Country Study.

Authors:  Noe Garin; Ai Koyanagi; Somnath Chatterji; Stefanos Tyrovolas; Beatriz Olaya; Matilde Leonardi; Elvira Lara; Seppo Koskinen; Beata Tobiasz-Adamczyk; Jose Luis Ayuso-Mateos; Josep Maria Haro
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-09-29       Impact factor: 6.053

Review 8.  Measuring coverage in MNCH: determining and interpreting inequalities in coverage of maternal, newborn, and child health interventions.

Authors:  Aluísio J D Barros; Cesar G Victora
Journal:  PLoS Med       Date:  2013-05-07       Impact factor: 11.069

9.  Socioeconomic Determinants of Multimorbidity: A Population-Based Household Survey of Hong Kong Chinese.

Authors:  Roger Y Chung; Stewart Mercer; Francisco T T Lai; Benjamin H K Yip; Martin C S Wong; Samuel Y S Wong
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

10.  Education, race/ethnicity, and multimorbidity among adults aged 30-64 in the National Health Interview Survey.

Authors:  Vicki Johnson-Lawrence; Anna Zajacova; Rodlescia Sneed
Journal:  SSM Popul Health       Date:  2017-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.